INHA and tuberculosis: To further demonstrate the value of our approach, we evaluated the conditional expression of three essential genes in M. smegmatis, namely, inhA, rpoB and ftsZ. Two of the chosen genes, inhA and rpoB are the molecular targets of the front line TB drugs, isoniazid and rifampicin respectively and therefore are clinically validated.